TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling
暂无分享,去创建一个
K. Horie-Inoue | S. Inoue | K. Kinowaki | T. Fujii | K. Ikeda | Kotaro Azuma | T. Saeki | A. Osaki | H. Kawabata | I. Sugitani | Kuniko Horie-Inoue | T. Fujii | T. Fujii | Keiichi Kinowaki